Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	598-599
Numero di pagine	2
Rivista	THE NEW ENGLAND JOURNAL OF MEDICINE
Volume	383
DOI	https://doi.org/10.1056/NEJMc2020754
Stato di pubblicazione	Pubblicato - 2020

Keywords

@article{f04573e3eb654329aa4af3761ae397df,

title = "Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply",

keywords = "HLH, EMAPALUMAB, HLH, EMAPALUMAB",

author = "Jordan, {Michael B.} and Franco Locatelli",

year = "2020",

doi = "10.1056/NEJMc2020754",

language = "English",

volume = "383",

pages = "598--599",

journal = "THE NEW ENGLAND JOURNAL OF MEDICINE",

issn = "1533-4406",

publisher = "Boston MA: Massachusetts Medical Society",

}

TY - JOUR

T1 - Emapalumab in Primary Hemophagocytic Lymphohistiocytosis. Reply

AU - Jordan, Michael B.

AU - Locatelli, Franco

PY - 2020

Y1 - 2020

KW - HLH

KW - EMAPALUMAB

KW - HLH

KW - EMAPALUMAB

UR - http://hdl.handle.net/10807/228273

U2 - 10.1056/NEJMc2020754

DO - 10.1056/NEJMc2020754

M3 - Article

SN - 1533-4406

VL - 383

SP - 598

EP - 599

JO - THE NEW ENGLAND JOURNAL OF MEDICINE

JF - THE NEW ENGLAND JOURNAL OF MEDICINE

ER -